Acadia Pharmaceuticals Inc

NASDAQ: ACAD
$16.18
-$0.09 (-0.6%)
Closing Price on November 21, 2024

ACAD Stock Chart and Intraday Price

ACAD Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 3,956.18M USD
Shares Outstanding 164,772,000
Acadia Pharmaceuticals Inc is a biopharmaceutical company based in San Diego, California, dedicated to developing and commercializing innovative medicines for central nervous system disorders and rare diseases. Its flagship product, NUPLAZID, treats hallucinations and delusions associated with Parkinson’s disease psychosis. Acadia is also advancing treatments for conditions like Rett Syndrome, schizophrenia, Prader-Willi syndrome, and Alzheimer’s disease psychosis, among others. The company, originally named Receptor Technologies, was founded in 1993 and emphasizes addressing unmet medical needs in neuropsychiatric conditions.

ACAD Articles

Wednesday's Top Wall Street Analyst Upgrades and Downgrades: Amazon, Arm, Corning, Dollar General, EA, Estee Lauder, Realty Income, Rivian and More
Wednesday's top analyst upgrades and downgrades included Amazon.com, Arm, Corning, Dollar General, Electronic Arts, Estee Lauder, Juniper Networks, Next Era Energy Partners, Realty Income, Rivian...
Lee Jackson
Published:

Huge July Employment Report: Analysts Upgrade or Downgrade Duke Energy, Paramount, Teva Pharmaceutical and More
Friday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, BioCryst Pharmaceuticals, Duke Energy, Kellogg, Paramount Global, Rhythm Pharmaceuticals and Teva...
Chris Lange
Published:

3 Big Ideas From Citigroup With Up to 80% Upside
Citigroup takes a look at a couple stocks with potentially huge upside and where they could go in light of a possible recession.
Chris Lange
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Chevron, Compass, Kraft Heinz, Micron Technology, Netflix, Nike, Seagate and More
Wednesday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Chevron, Compass, ConocoPhillips, Kraft Heinz, Micron Technology, Netflix, Nike, Seagate Technology, Shoals...
Lee Jackson
Published:
Last Updated:

Tuesday's Big Bounce: Analysts Upgrade or Downgrade Etsy, Keurig Dr Pepper and More
Tuesday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, CarGurus, CubeSmart, Etsy, Keurig Dr Pepper and Molson Coors Beverage.
Chris Lange
Published:

Friday's Top Analyst Upgrades and Downgrades: Amgen, AutoZone, Boeing, Dollar General, Etsy, FedEx, Unity Software, Warner Bros. Discovery and More
Friday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, Fidelity National Information Services, FedEx, NexTier...
Lee Jackson
Published:

More Wednesday Analyst Upgrades and Downgrades: Biopharma Stocks Beware -- Johnson & Johnson, Edwards Life Sciences and More
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.
Chris Lange
Published:

Wednesday Afternoon's Top Analyst Upgrades and Downgrades: General Motors, Lyft, Tenet Healthcare, Vale and More
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Enphase Energy, General Motors, Incyte, Lyft, MP Materials, Newmont, Tenet Healthcare and Vale.
Chris Lange
Published:

Wednesday Afternoon Analyst Upgrades and Downgrades: Altria, BP, Peloton, Pfizer and More
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer,...
Chris Lange
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Biogen, Goodyear, Krispy Kreme, Lockheed Martin, Micron Technology, Microsoft, Nike and More
Wednesday's early top analyst upgrades and downgrades included Biogen, Goodyear Tire, Hippo, Krispy Kreme, Lockheed Martin, Micron Technology, Microsoft, Nike and Patterson-UTI Energy.
Lee Jackson
Published:

Tuesday Afternoon's Analyst Upgrades and Downgrades: Cigna, Comerica, Oracle and More
Tuesday afternoon's top analyst upgrades and downgrades included Boot Barn, Cigna, Comerica, GoodRx, Oracle and United Rentals.
Chris Lange
Published:

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More
Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.
Chris Lange
Published:

Thursday Afternoon Analyst Upgrades and Downgrades: Deere, NetApp, Petrobras, TJX and More
Thursday afternoon's analyst upgrades and downgrades included Deere, NetApp, Petrobras and TJX Companies.
Chris Lange
Published:

4 Bullish Stock Picks After Earnings With Huge Potential Upside
JMP Securities has come out with a few stock picks that it thinks will outperform in the coming months.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Airbnb, Chevron, Coupang, Freeport-McMoRan, Peloton, Snap, Wynn, Zillow and More
Tuesday's top analyst upgrades and downgrades included Airbnb, Chevron, Coupang, Freeport-McMoRan, Peloton Interactive, Snap, Wynn Resorts and Zillow.
Lee Jackson
Published: